cropped-cropped-favicon-270x270-1.png

At MediMix, we are dedicated to keeping Belgian healthcare professionals at the forefront of medicine. Our team brings you high-value insights from leading congresses worldwide, across key disease areas including oncology. In collaboration with Belgian and international experts, we transform the latest data into practical knowledge.

Congress reports

Now live

Now live

Now live

Now live

Past congresses

What's New Doc?

Latest publications

ALEX study

At the ESMO 2025 congress, the final OS results of the ALEX trial were presented, marking a key milestone in the management of ALK–rearranged advanced NSCLC.

See video »

The PHAROS trial

In this video, Dr Anouk Goudsmit, medical oncologist discusses updated results of the phase II PHAROS trial, evaluating the combination of encorafenib and binimetinib in patients with BRAFV600E mutant metastatic

See video »

The IMforte trial

In this video, Dr Dieter Stevens, pulmonologist and thoracic oncologist at the Ghent University Hospital, and Prof Luis Paz-Ares, medical oncologist at the Hospital Universitario 12 de Octubre in Madrid,

See video »

The DeLLphi-304 study

At the 2025 ESMO Congress, updated data focusing on safety and subgroup analyses were presented, providing a more comprehensive understanding of the clinical profile of tarlatamab. The key takeaways of

See video »